{"title":"以治疗为目的使用迷幻药会降低有儿童虐待史的成年人的羞耻感和复杂创伤症状。","authors":"C J Healy, Kellie Ann Lee, Wendy D'Andrea","doi":"10.1177/24705470211029881","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Child maltreatment negatively affects the formation of internal schemata of self and other during development, leading to negative adaptations in self-concept and social cognition. Clinical reports suggest the efficacy of psychedelics in treating the psychopathological sequelae of child maltreatment. Altering maladaptive schemata of self and other implicated in negative self-concept and impaired social cognition may be a central mechanism for reducing posttraumatic stress symptoms.</p><p><strong>Aims: </strong>This study aims to assess whether psychedelic use moderates the relationships between child maltreatment and self-concept, social cognition, and posttraumatic stress symptoms.</p><p><strong>Method: </strong>An online survey was completed by 166 participants and included measures of maltreatment exposure and severity, history of intentional therapeutic psychedelic use, posttraumatic stress symptoms, internalized shame, and facial emotion recognition.</p><p><strong>Results: </strong>Child maltreatment significantly correlated with posttraumatic stress symptoms (<i>r</i> = .26 and <i>r</i> = .20, <i>p</i> < .01) and internalized shame (<i>r</i> = .18, <i>p</i> < .05). Of all maltreatment subtypes, emotional abuse and neglect most strongly correlated with complex trauma symptoms (<i>r</i> = .32, <i>p</i> < .001) and internalized shame (<i>r</i> = .31, <i>p</i> < .001). Participants with a history of intentional therapeutic psychedelic use reported significantly lower complex trauma symptoms (<i>d</i> = 0.33, <i>p</i> < .05) and internalized shame (<i>d</i> = 0.35, <i>p</i> < .05) despite similar histories of maltreatment. Differences in complex trauma symptoms (<i>d</i> = 0.66, <i>p</i> < .01) and internalized shame (<i>d</i> = 0.80, <i>p</i> < .001) were largest for participants with a history of more than 5 occasions of intentional therapeutic psychedelic use. A history of more than 5 occasions of intentional therapeutic psychedelic use significantly moderated the relationship between emotional abuse and neglect and complex trauma symptoms (p < .01). No associations were found between maltreatment or psychedelic use and facial emotion recognition.</p><p><strong>Conclusion: </strong>These findings demonstrate that using psychedelic drugs with therapeutic intent is associated with lower levels of complex trauma symptoms and internalized shame in individuals with histories of child maltreatment. Psychedelic use may have therapeutic benefit in treating the posttraumatic sequelae of child maltreatment.</p>","PeriodicalId":52315,"journal":{"name":"Chronic Stress","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/c3/10.1177_24705470211029881.PMC8278461.pdf","citationCount":"0","resultStr":"{\"title\":\"Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.\",\"authors\":\"C J Healy, Kellie Ann Lee, Wendy D'Andrea\",\"doi\":\"10.1177/24705470211029881\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Child maltreatment negatively affects the formation of internal schemata of self and other during development, leading to negative adaptations in self-concept and social cognition. Clinical reports suggest the efficacy of psychedelics in treating the psychopathological sequelae of child maltreatment. Altering maladaptive schemata of self and other implicated in negative self-concept and impaired social cognition may be a central mechanism for reducing posttraumatic stress symptoms.</p><p><strong>Aims: </strong>This study aims to assess whether psychedelic use moderates the relationships between child maltreatment and self-concept, social cognition, and posttraumatic stress symptoms.</p><p><strong>Method: </strong>An online survey was completed by 166 participants and included measures of maltreatment exposure and severity, history of intentional therapeutic psychedelic use, posttraumatic stress symptoms, internalized shame, and facial emotion recognition.</p><p><strong>Results: </strong>Child maltreatment significantly correlated with posttraumatic stress symptoms (<i>r</i> = .26 and <i>r</i> = .20, <i>p</i> < .01) and internalized shame (<i>r</i> = .18, <i>p</i> < .05). Of all maltreatment subtypes, emotional abuse and neglect most strongly correlated with complex trauma symptoms (<i>r</i> = .32, <i>p</i> < .001) and internalized shame (<i>r</i> = .31, <i>p</i> < .001). Participants with a history of intentional therapeutic psychedelic use reported significantly lower complex trauma symptoms (<i>d</i> = 0.33, <i>p</i> < .05) and internalized shame (<i>d</i> = 0.35, <i>p</i> < .05) despite similar histories of maltreatment. Differences in complex trauma symptoms (<i>d</i> = 0.66, <i>p</i> < .01) and internalized shame (<i>d</i> = 0.80, <i>p</i> < .001) were largest for participants with a history of more than 5 occasions of intentional therapeutic psychedelic use. A history of more than 5 occasions of intentional therapeutic psychedelic use significantly moderated the relationship between emotional abuse and neglect and complex trauma symptoms (p < .01). No associations were found between maltreatment or psychedelic use and facial emotion recognition.</p><p><strong>Conclusion: </strong>These findings demonstrate that using psychedelic drugs with therapeutic intent is associated with lower levels of complex trauma symptoms and internalized shame in individuals with histories of child maltreatment. Psychedelic use may have therapeutic benefit in treating the posttraumatic sequelae of child maltreatment.</p>\",\"PeriodicalId\":52315,\"journal\":{\"name\":\"Chronic Stress\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/c3/10.1177_24705470211029881.PMC8278461.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chronic Stress\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/24705470211029881\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Psychology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Stress","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24705470211029881","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}
引用次数: 0
摘要
背景:儿童在成长过程中受到虐待会对自我和他人内部图式的形成产生负面影响,从而导致自我概念和社会认知方面的消极适应。临床报告显示,迷幻药对治疗儿童虐待后遗症具有疗效。目的:本研究旨在评估使用迷幻药是否会调节儿童虐待与自我概念、社会认知和创伤后应激症状之间的关系:166名参与者完成了一项在线调查,调查内容包括虐待暴露和严重程度、有意使用治疗性迷幻药的历史、创伤后应激症状、内化的羞耻感和面部情绪识别:结果:儿童虐待与创伤后应激症状明显相关(r = .26 和 r = .20,p r = .18,p r = .32,p r = .31,p d = 0.33,p d = 0.35,p d = 0.66,p d = 0.80,p 结论:儿童虐待与创伤后应激症状明显相关:这些研究结果表明,出于治疗目的使用迷幻药与儿童虐待史患者较低程度的复杂创伤症状和内化羞耻感有关。使用迷幻药可能对治疗虐待儿童的创伤后遗症有益。
Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.
Background: Child maltreatment negatively affects the formation of internal schemata of self and other during development, leading to negative adaptations in self-concept and social cognition. Clinical reports suggest the efficacy of psychedelics in treating the psychopathological sequelae of child maltreatment. Altering maladaptive schemata of self and other implicated in negative self-concept and impaired social cognition may be a central mechanism for reducing posttraumatic stress symptoms.
Aims: This study aims to assess whether psychedelic use moderates the relationships between child maltreatment and self-concept, social cognition, and posttraumatic stress symptoms.
Method: An online survey was completed by 166 participants and included measures of maltreatment exposure and severity, history of intentional therapeutic psychedelic use, posttraumatic stress symptoms, internalized shame, and facial emotion recognition.
Results: Child maltreatment significantly correlated with posttraumatic stress symptoms (r = .26 and r = .20, p < .01) and internalized shame (r = .18, p < .05). Of all maltreatment subtypes, emotional abuse and neglect most strongly correlated with complex trauma symptoms (r = .32, p < .001) and internalized shame (r = .31, p < .001). Participants with a history of intentional therapeutic psychedelic use reported significantly lower complex trauma symptoms (d = 0.33, p < .05) and internalized shame (d = 0.35, p < .05) despite similar histories of maltreatment. Differences in complex trauma symptoms (d = 0.66, p < .01) and internalized shame (d = 0.80, p < .001) were largest for participants with a history of more than 5 occasions of intentional therapeutic psychedelic use. A history of more than 5 occasions of intentional therapeutic psychedelic use significantly moderated the relationship between emotional abuse and neglect and complex trauma symptoms (p < .01). No associations were found between maltreatment or psychedelic use and facial emotion recognition.
Conclusion: These findings demonstrate that using psychedelic drugs with therapeutic intent is associated with lower levels of complex trauma symptoms and internalized shame in individuals with histories of child maltreatment. Psychedelic use may have therapeutic benefit in treating the posttraumatic sequelae of child maltreatment.